Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience

Kaya Erdogan, Hilal; Saracoglu, Zeynep Nurhan; Acer, Ersoy; Agaoglu, Esra

doi:10.4274/eamr.galenos.2021.57442

Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience

Esra AĞAOĞLU, (Kars Harakani Devlet Hastanesi, Dermatoloji Kliniği, Kars, Türkiye)

Hilal KAYA ERDOĞAN, (Eskişehir Osmangazi Üniversitesi Tıp Fakültesi, Dermatoloji Anabilim Dalı, Eskişehir, Türkiye)

Ersoy ACER, (Eskişehir Osmangazi Üniversitesi Tıp Fakültesi, Dermatoloji Anabilim Dalı, Eskişehir, Türkiye)

Zeynep SARAÇOĞLU (Eskişehir Osmangazi Üniversitesi Tıp Fakültesi, Dermatoloji Anabilim Dalı, Eskişehir, Türkiye)

European Archives of Medical Research

2 0

Yıl: 2022 Cilt: 38 Sayı: 4 Sayfa Aralığı: 255 - 260 Metin Dili: İngilizce DOI: 10.4274/eamr.galenos.2021.57442 İndeks Tarihi: 08-05-2023

Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience

Öz:

Objective: Chronic skin diseases can negatively affect the quality of life. They may cause impairment of work productivity and have a socio- economical burden. In this study, we evaluated patients who applied to our hospital for the determination of disability due to chronic skin diseases. Methods: We retrospectively evaluated the patients who were given a disability rate by our department between 2008 and 2018. The demographic features of the patients, diagnosis of the skin disease, involved areas of the body and accompanying comorbidities were recorded. Skin diseases were classified and rates of disabilities were determined according to the Ministry of Family, Labor and Social Services and the Ministry of Health’s disability assessment scale for adults. Results: A total of 137 patients were included in the study. Eighty-two (59.8%) of the patients were male and 55 (40.1%) were female. The mean rate of disability due to skin diseases was 11.31±10.91. The mean rate of disability was 12.0 for male patients and 10.2 for female patients. The most common diseases causing disability were inflammatory skin diseases (22.6%), skin manifestations of autoimmune and systemic skin diseases (18.9%), skin tumors (16.7%) and eczema (11.6%). Psoriasis vulgaris is the most common (96.6%) inflammatory skin disease. Of the skin manifestations of autoimmune and systemic skin diseases, Behçet’s disease (34.6%) accounted for most patients, while autoimmune bullous diseases had the highest rate of disability. Malignant melanoma had the highest disability rates among skin tumors. Among the eczema group, patients with contact dermatitis (62.5%) had the highest rate of disability. Patients with genetic skin diseases, such as ichthyosis, epidermolysis bullosa and lipoid proteinosis, had the highest rate of disability overall. Conclusion: Chronic skin diseases may cause disability as well as a decrease in quality of life. Patients with chronic skin disease should be evaluated with their psychological and occupational aspects.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Hay RJ, Fuller LC. The assessment of dermatological needs in resource- poor regions. Int J Dermatol 2011;50:552-7.
2. Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 2014;134:1527-34.
3. Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 2000;143:969-73.
4. Hong J, Koo B, Koo J. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther 2008;21:54-9.
5. Amado A, Taylor JS. Women’s occupational dermatologic issues. Dermatol Clin 2006;24:259-69, vii.
6. Resmî Gazete Özürlülük Ölçütü, Sınıflandırması ve Özürlülere Verilecek Sağlık Kurulu Raporları Hakkında Yönetmelik, ek-2 . T.C. Resmi Gazete, sayı: 30692. 20.02.2019.
7. Ibler KS, Jemec GB. Permanent disability pension due to skin diseases in Denmark 2003-2008. Acta Dermatovenerol Croat 2011;19:161-4.
8. Basra MK, Shahrukh M. Burden of skin diseases. Expert Rev Pharmacoecon Outcomes Res 2009;9:271-83.
9. Lim YL, Goon A. Occupational skin diseases in Singapore 2003-2004: an epidemiologic update. Contact Dermatitis 2007;56:157-9.
10. Feldman S, Behnam SM, Behnam SE, Koo JY. Involving the patient: impact of inflammatory skin disease and patient-focused care. J Am Acad Dermatol 2005;53(Suppl 1):S78-85.
11. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:236-44.
12. Chan B, Hales B, Shear N, Ho V, Lynde C, Poulin Y, et al. Work-related lost productivity and its economic impact on Canadian patients with moderate to severe psoriasis. J Cutan Med Surg 2009;13:192-7.
13. Kimball AB, Yu AP, Signorovitch J, Xie J, Tsaneva M, Gupta SR, et al. The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis. J Am Acad Dermatol 2012;66:e67-76.
14. Thomsen SF, Skov L, Dodge R, Hedegaard MS, Kjellberg J. Socioeconomic costs and health inequalities from psoriasis: a cohort study. Dermatology 2019;235:372-9.
15. Gudu T, Gossec L. Quality of life in psoriatic arthritis. Expert Rev Clin Immunol 2018;14:405-17.
16. Seyhan M, Aki T, Karincaoglu Y, Ozcan H. Psychiatric morbidity in dermatology patients: Frequency and results of consultations. Indian J Dermatol 2006;51:18-22.
17. Erdogan HK, Altinoz AE, Acer E, Saracoglu ZN, Bilgin M. Evaluation of anxiety sensitivity in patients with psoriasis. Dermatol Sin 2019;37:28- 32.
18. Hatemi G, Merkel PA, Hamuryudan V, Boers M, Direskeneli H, Aydin SZ, et al. Outcome measures used in clinical trials for Behçet syndrome: a systematic review. J Rheumatol 2014;41:599-612.
19. Idil A, Gürler A, Boyvat A, Caliskan D, Ozdemir O, Isik A, et al. The prevalence of Behçet’s disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic Epidemiol 2002;9:325-31.
20. Sut N, Seyahi E, Yurdakul S, Senocak M, Yazici H. A cost analysis of Behcet’s syndrome in Turkey. Rheumatology (Oxford) 2007;46:678-82.
21. Mumcu G, Lehimci F, Fidan Ö, Gük H, Alpar U, Ünal AU, et al. The assessment of work productivity and activity impairment in Behçet’s disease. Turk J Med Sci 2017;47:535-41.
22. Heelan K, Hitzig SL, Knowles S, Drucker AM, Mittmann N, Walsh S, et al. Loss of work productivity and quality of life in patients with autoimmune bullous dermatoses. J Cutan Med Surg 2015;19:546-54.
23. Penha MÁ, Farat JG, Miot HA, Barraviera SR. Quality of life index in autoimmune bullous dermatosis patients. An Bras Dermatol 2015;90:190-4.
24. Brodszky V, Tamási B, Hajdu K, Péntek M, Szegedi A, Sárdy M, et al. Disease burden of patients with pemphigus from a societal perspective. Expert Rev Pharmacoecon Outcomes Res 2021;21:77-86.
25. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004;150:179-85.
26. Guy GP, Ekwueme DU. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature. Pharmacoeconomics 2011;29:863-74.
27. Holterhues C, Cornish D, van de Poll-Franse LV, Krekels G, Koedijk F, Kuijpers D, et al. Impact of melanoma on patients’ lives among 562 survivors: a Dutch population-based study. Arch Dermatol 2011;147:177-85.
28. Holterhues C, Hollestein LM, Nijsten T, Koomen ER, Nusselder W, de Vries E. Burden of disease due to cutaneous melanoma has increased in the Netherlands since 1991. Br J Dermatol 2013;169:389-97.
29. Belsito DV. Occupational contact dermatitis: etiology, prevalence, and resultant impairment/disability. J Am Acad Dermatol 2005;53:303-13.
30. Meding B, Wrangsjö K, Burdorf A, Järvholm B. Disability pensions due to skin diseases: a cohort study in Swedish construction workers. Acta Derm Venereol 2016;96:232-6.
31. Mälkönen T, Alanko K, Jolanki R, Luukkonen R, Aalto-Korte K, Lauerma A, et al. Long-term follow-up study of occupational hand eczema. Br J Dermatol 2010;163:999-1006.
32. Tabolli S, Sampogna F, Di Pietro C, Paradisi A, Uras C, Zotti P, et al. Quality of life in patients with epidermolysis bullosa. Br J Dermatol 2009;161:869-77.
33. Dreyfus I, Pauwels C, Bourrat E, Bursztejn AC, Maruani A, Chiaverini C, et al. Burden of inherited ichthyosis: a French national survey. Acta Derm Venereol 2015;95:326-8.
34. Margari F, Lecce PA, Santamato W, Ventura P, Sportelli N, Annicchiarico G, et al. Psychiatric symptoms and quality of life in patients affected by epidermolysis bullosa. J Clin Psychol Med Settings 2010;17:333-9.
35. Angelis A, Tordrup D, Kanavos P. Socio-economic burden of rare diseases: a systematic review of cost of illness evidence. Health Policy 2015;119:964-79.
36. Herbosa CM, Semenov YR, Rosenberg AR, Mehta-Shah N, Musiek AC. Clinical severity measures and quality-of-life burden in patients with mycosis fungoides and Sézary syndrome: comparison of generic and dermatology-specific instruments. J Eur Acad Dermatol Venereol 2020;34:995-1003.
37. Demierre MF, Gan S, Jones J, Miller DR. Significant impact of cutaneous T-cell lymphoma on patients’ quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey. Cancer 2006;107:2504-11.
38. Engin B, Keçici AS, Uzun AÖ, Yalçın M. Psychiatric comorbidity, depression, and anxiety levels and quality of life of the patients with mycosis fungoides. Dermatol Ther 2020;33:e13922.

APA	Agaoglu E, Kaya Erdogan H, Acer E, Saracoglu Z (2022). Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience. , 255 - 260. 10.4274/eamr.galenos.2021.57442
Chicago	Agaoglu Esra,Kaya Erdogan Hilal,Acer Ersoy,Saracoglu Zeynep Nurhan Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience. (2022): 255 - 260. 10.4274/eamr.galenos.2021.57442
MLA	Agaoglu Esra,Kaya Erdogan Hilal,Acer Ersoy,Saracoglu Zeynep Nurhan Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience. , 2022, ss.255 - 260. 10.4274/eamr.galenos.2021.57442
AMA	Agaoglu E,Kaya Erdogan H,Acer E,Saracoglu Z Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience. . 2022; 255 - 260. 10.4274/eamr.galenos.2021.57442
Vancouver	Agaoglu E,Kaya Erdogan H,Acer E,Saracoglu Z Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience. . 2022; 255 - 260. 10.4274/eamr.galenos.2021.57442
IEEE	Agaoglu E,Kaya Erdogan H,Acer E,Saracoglu Z "Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience." , ss.255 - 260, 2022. 10.4274/eamr.galenos.2021.57442
ISNAD	Agaoglu, Esra vd. "Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience". (2022), 255-260. https://doi.org/10.4274/eamr.galenos.2021.57442

APA	Agaoglu E, Kaya Erdogan H, Acer E, Saracoglu Z (2022). Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience. European Archives of Medical Research, 38(4), 255 - 260. 10.4274/eamr.galenos.2021.57442
Chicago	Agaoglu Esra,Kaya Erdogan Hilal,Acer Ersoy,Saracoglu Zeynep Nurhan Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience. European Archives of Medical Research 38, no.4 (2022): 255 - 260. 10.4274/eamr.galenos.2021.57442
MLA	Agaoglu Esra,Kaya Erdogan Hilal,Acer Ersoy,Saracoglu Zeynep Nurhan Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience. European Archives of Medical Research, vol.38, no.4, 2022, ss.255 - 260. 10.4274/eamr.galenos.2021.57442
AMA	Agaoglu E,Kaya Erdogan H,Acer E,Saracoglu Z Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience. European Archives of Medical Research. 2022; 38(4): 255 - 260. 10.4274/eamr.galenos.2021.57442
Vancouver	Agaoglu E,Kaya Erdogan H,Acer E,Saracoglu Z Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience. European Archives of Medical Research. 2022; 38(4): 255 - 260. 10.4274/eamr.galenos.2021.57442
IEEE	Agaoglu E,Kaya Erdogan H,Acer E,Saracoglu Z "Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience." European Archives of Medical Research, 38, ss.255 - 260, 2022. 10.4274/eamr.galenos.2021.57442
ISNAD	Agaoglu, Esra vd. "Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience". European Archives of Medical Research 38/4 (2022), 255-260. https://doi.org/10.4274/eamr.galenos.2021.57442